Tuesday, March 10, 2015 12:24:22 PM
For the nine months ended September 30, 2014, the Company had a net loss of $705,245. As of September 30, 2014, the Company has a working capital deficit of $248,121. In view of these matters, the Company’s ability to continue as a going concern is dependent upon the Company’s ability to begin operations and to achieve a level of profitability. The Company intends on financing its future development activities and its working capital needs largely from the sale of public equity securities with some additional funding from other traditional financing sources, including term notes and proceeds from sub-licensing agreements until such time that funds provided by operations are sufficient to fund working capital requirements.
Recent NVOS News
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 09/23/2024 12:30:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2024 10:05:09 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 08:50:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/19/2024 09:05:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 09:00:45 PM
- Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results • Business Wire • 07/19/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 08:05:16 PM
- Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program • Business Wire • 07/18/2024 08:05:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 07/15/2024 08:15:26 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/08/2024 09:16:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:30:34 PM
- Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program • Business Wire • 06/13/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 07:30:13 PM
- Novo Integrated Sciences’ Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million • Business Wire • 06/06/2024 07:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 07:00:19 PM
- Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products • Business Wire • 06/05/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 07:00:34 PM
- Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note • Business Wire • 06/03/2024 07:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 01:00:14 PM
- Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program • Business Wire • 05/31/2024 01:00:00 PM
- Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program • Business Wire • 05/30/2024 08:30:00 PM
- Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results • Business Wire • 04/15/2024 08:30:00 PM
- Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement • Business Wire • 04/11/2024 09:00:00 PM
- Novo Integrated Sciences Provides Update on Certain Current Actions and Events • Business Wire • 03/26/2024 06:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:05:40 PM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM